We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
-13.93%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$20B
AUM Growth
-$5.25B
Cap. Flow
-$1.13B
Cap. Flow %
-5.62%
Top 10 Hldgs %
21.83%
Holding
1,650
New
389
Increased
426
Reduced
533
Closed
104

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$109M
2
ABBV icon
AbbVie
ABBV
+$68.7M
3
ORCL icon
Oracle
ORCL
+$63.5M
4
KO icon
Coca-Cola
KO
+$54.4M
5
ABT icon
Abbott
ABT
+$52.2M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$112M
2
AAPL icon
Apple
AAPL
+$97.1M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$87.3M
4
NVDA icon
NVIDIA
NVDA
+$66.6M
5
MSFT icon
Microsoft
MSFT
+$63M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Healthcare 21.45%
3 Financials 13.18%
4 Consumer Discretionary 9.11%
5 Consumer Staples 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RC
1301
Ready Capital
RC
$260M
$65K ﹤0.01%
+5,432
New +$76.5K
CEVA icon
1302
CEVA Inc
CEVA
$831M
$64K ﹤0.01%
+1,920
New +$67.7K
PARR icon
1303
Par Pacific Holdings
PARR
$4.17B
$64K ﹤0.01%
+4,087
New +$64.4K
HA
1304
DELISTED
Hawaiian Holdings, Inc.
HA
$64K ﹤0.01%
+4,488
New +$75K
RPT
1305
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$64K ﹤0.01%
+6,556
New +$79.5K
AORT icon
1306
Artivion
AORT
$1.34B
$63K ﹤0.01%
+3,311
New +$63.9K
CCSI icon
1307
Consensus Cloud Solutions
CCSI
$675M
$63K ﹤0.01%
+1,441
New +$71.6K
TBI
1308
Trueblue
TBI
$227M
$63K ﹤0.01%
3,544
-8,156
-70% -$191K
XPEL icon
1309
XPEL
XPEL
$1.22B
$63K ﹤0.01%
+1,362
New +$64.3K
ROCC
1310
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$63K ﹤0.01%
+1,914
New +$72.1K
CVGW
1311
DELISTED
Calavo Growers
CVGW
$62K ﹤0.01%
+1,487
New +$53.9K
ICHR icon
1312
Ichor Holdings
ICHR
$2.17B
$62K ﹤0.01%
+2,387
New +$69.1K
NKTR icon
1313
Nektar Therapeutics
NKTR
$2.39B
$62K ﹤0.01%
1,082
+465
+75% +$29.3K
TILE icon
1314
Interface
TILE
$1.95B
$62K ﹤0.01%
+4,907
New +$65K
VSXY
1315
Victoria's Secret
VSXY
$7.09B
$62K ﹤0.01%
2,218
KELYA icon
1316
Kelly Services Class A
KELYA
$548M
$61K ﹤0.01%
+3,097
New +$60.8K
AEO icon
1317
American Eagle Outfitters
AEO
$2.94B
$60K ﹤0.01%
5,400
VNDA icon
1318
Vanda Pharmaceuticals
VNDA
$304M
$60K ﹤0.01%
5,483
-5,389
-50% -$55.8K
WSR
1319
DELISTED
Whitestone REIT
WSR
$60K ﹤0.01%
5,577
-3,817
-41% -$45.9K
COLL icon
1320
Collegium Pharmaceutical
COLL
$1.18B
$59K ﹤0.01%
3,355
-15,366
-82% -$258K
GCO icon
1321
Genesco
GCO
$434M
$59K ﹤0.01%
+1,183
New +$70.9K
SSP icon
1322
E.W. Scripps
SSP
$270M
$59K ﹤0.01%
+4,740
New +$75.8K
WT icon
1323
WisdomTree
WT
$2.79B
$59K ﹤0.01%
11,677
-22,990
-66% -$132K
BIG
1324
DELISTED
Big Lots, Inc.
BIG
$59K ﹤0.01%
+2,817
New +$82.9K
HWKN icon
1325
Hawkins
HWKN
$2.9B
$58K ﹤0.01%
+1,603
New +$60.6K

Similar funds

KBC Group's Q2 2022 Portfolio in Review

As of Q2 2022, KBC Group held 1,650 positions worth $20B, down 21% from $25.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

KBC Group withdrew a net $1.13B in Q2 2022, closing 104 positions and reducing 533 holdings. Its most notable exit was Cerner Corp, an estimated $17.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.

Against the trend, KBC Group opened a new position in AstraZeneca worth $1.34M.

  • KBC Group's largest Q2 2022 buy was AstraZeneca: 10,181 shares worth $1.34M.
  • KBC Group added most to Merck in Q2 2022, an estimated $109M increase.
  • KBC Group's biggest Q2 2022 reduction was Amazon, cutting an estimated $112M.
  • KBC Group fully exited Cerner Corp in Q2 2022, selling an estimated $17.5M.
  • KBC Group's ten largest holdings make up 22% of its $20B portfolio in Q2 2022.
  • KBC Group opened 389 new positions and closed 104 in Q2 2022.
  • KBC Group's portfolio value fell 21% quarter-over-quarter to $20B.

Based on KBC Group's 13F filing for Q2 2022, filed 26 Jul 2022.